Inventaire - your friends and communities are your best library

Can intellectualism stifle scientific discovery?

Published in: Nature Reviews Drug Discovery

Date of publication: October 1, 2002

Bibliographic databases:

Cites articles 26

Date

Title

Authors

May 1, 1972

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations
October 1, 1975

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
April 1, 1979

Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain
June 1, 1985

Postoperative pain relief with naloxone. Severe respiratory depression and pain after high dose buprenorphine
October 1, 1989

Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins
December 1, 1993

Phosphodiesterase inhibitors. Do the risks outweight the benefits?
April 1, 1994

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor
February 1, 1994

Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence
November 1, 1995

Inotropic therapy for the failing myocardium
March 1, 1995

Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor
November 1, 1995

The slowing of treatment discovery, 1965–1995
April 1, 1995

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
May 1, 1996

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
May 1, 1997

Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice
September 1, 1998

Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions
June 12, 1999

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
August 1, 1999

Rise and fall of modern medicine
March 1, 2000

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

, ,
February 1, 2000

Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability
April 1, 2000

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

, ,
January 1, 2000

Treatment of heart failure with beta-blockers. Mechanisms and results
June 1, 2001

Is paradoxical pharmacology a strategy worth pursuing?
2001

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
October 1, 2001

Unbalanced research
January 1, 2002

Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization
April 1, 2002

Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation

Article -

Welcome to inventaire

The library of your friends and communities

Learn more